Why Pfizer Is My Largest Healthcare Position
Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment toward the healthcare sector, but in some instances, this dour take isn't entirely warranted. Pharmaceutical titan (NYSE: PFE) is a case in point.
The drugmaker's shares have lost 47% of their value from their three-year high and currently trade near a historically low forward price-to-earnings ratio (P/E) of just 8.7. Here's why Pfizer is my largest healthcare position, despite its poor showing over the past few years.
Image source: Getty Images.
Source Fool.com
Pfizer Inc. Aktie
21,86 €
0,71 %
Die Community neigt bei Pfizer Inc. zu Buy-Einschätzungen, mit einigen mehr als Sell-Einschätzungen.
Das von der Community festgelegte Kursziel für Pfizer Inc. von 29 € impliziert eine deutliche Steigerung gegenüber dem aktuellen Kurs von 21.86 €.
